N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Mayo Clinic
Case Comprehensive Cancer Center
University of California, San Francisco
University of California, San Francisco
M.D. Anderson Cancer Center
Montefiore Medical Center
University of Washington
University of California, Davis
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
University of Chicago
National University Hospital, Singapore
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National University Hospital, Singapore
M.D. Anderson Cancer Center
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal